breast cancer
Conditions
Interventions
Irradiating weak microwaves to breast surface
Sponsors
Kunihisa Tomonari
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Selection criteria for breast cancer or suspected breast cancer (1) Apply to any of the following (a) Histologically diagnosed breast cancer by needle biopsy or aspiration tissue biopsy (b) Breast cancer is suspected by examination with a breast X-ray diagnostic device or examination with a breast ultrasound imaging device. (2) Aged 20 or older at the time of informed consent. (3) Receive a full explanation of the content of this clinical study from the principal investigator or co-investigator using a consent document and an explanatory document, and consent to participate in this clinical research voluntarily. However, it is only possible to obtain consent from the research subject themselves. Selection criteria for those who do not have or are not suspected of having breast cancer If it becomes clear that the following criteria are not met from case registration to m-MG-01 testing, m-MG-01 testing will not be started. (1) Breast cancer is not suspected at the time of participation in this study. (2) Aged 20 or older at the time of informed consent. (3) Agree to participate in this clinical research of my own free will after receiving a full explanation of the details of this clinical research from the principal investigator or a subinvestigator of the clinical research using the consent document and the explanation document. However, it is only possible to obtain consent from the research subject themselves.
Exclusion criteria
Exclusion criteria: (1) There is a trauma with bleeding and tumor bleeding on the breast surface. (2) Within 7 days after needle biopsy or aspiration tissue biopsy was performed. (3) Wearing a bioimplantable device such as a pacemaker. (4) Has a history of serious psychiatric disease or is under treatment and the principal investigator or sub-investigator judged that it would be difficult to participate in this clinical study. (5) Unable to maintain supine position in bed during m-MG-01 (approximatly 20 minutes). (6) Unable to maintain the arm raised to the head side during m-MG-01.(Approximately 10 minutes). (7) In addition the primary investigator or sub-investigator determined that the subject was inappropriate as a research subject.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| First wave intensity value in inspection by m-MG-01 | — |
Secondary
| Measure | Time frame |
|---|---|
| Malfunction such as disease | — |
Contacts
Public ContactTomonari Kunihisa
Kobe University Hospital
Outcome results
None listed